Table 1

DGAST and PNET patient demographics

Identification	Clinical diagnosis	Age	MEN1 syndrome	ZES	Mets	Tumour grade (WHO)	Ki67 (%)	RNA-seq	WES
87	Duodenal gastrinoma	43	+	−	+	1	<1	+	−
215	Duodenal gastrinoma	32	+	+	+	2	10	+	+
219	Duodenal gastrinoma	70	−	+	+	2	12	+	+
269	Duodenal gastrinoma	57	−	−	+	1	2	+	+
290	DNET	50	−	−	−	1	<2	−	+
48	Gastrinoma PNET	47	+	+	+	1	n/a	−	+
134	VIPoma PNET	50	+	−	−	1	<2	+	+
136	Non-functional PNET	50	−	−	−	1	2	+	+
299	Non-functional PNET	67	−	−	+	2	7	−	+
358	Non-functional PNET	49	−	−	−	1	2	+	−
362	Non-functional PNET	47	−	−	−	1	2	−	+
371	Non-functional PNET	74	−	−	+	2	9	+	−
396	Non-functional PNET	63	−	−	−	2	6	+	−
401	Glucagonoma PNET	63	−	−	−	1	<2	+	−

DGAST, duodenal gastrinoma; DNET, duodenal neuroendocrine tumour; MEN1, multiple endocrine neoplasia, type 1; Mets, Metastasis; n/a, not available; PNET, pancreatic neuroendocrine tumour; RNA-seq, RNA-sequencing; WES, whole exome sequencing; ZES, Zollinger-Ellison Syndrome.